News
News
PAN
Owlstone Medical Announces Key Study Results on use of Breath Biopsy for Improved Detection of Liver Disease including NASH and NAFLD
Study results support Owlstone Medical’s development of breath-based diagnostic and prognostic tests for liver disease Data validates Owlstone Medical’s EVOC® Probe strategy for breath-based diagnostic test development Results published in Clinical and Translational Gastroenterology Cambridge, UK, September 22 2020: Owlstone Medical, the global leader in Breath Biopsy® for applications in early ...
Press releases
Owlstone Medical Appoints Neil Tween as Chief Financial Officer
Press releases
Owlstone Medical named as one of FierceMedTech’s “Fierce 15” companies of 2019
Press releases
Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure
Press releases
Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-Invasive Breath Biopsy
Press releases
Owlstone Medical to Contribute Breath Biopsy to 3TR, the Largest-ever IMI2 Immunology Project to Improve Disease Management Across Seven Immune-Mediated Diseases
Cleveland Clinic Partners with Owlstone Medical to Establish New Center
Press releases
Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply
Press releases
Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease
Press releases
Owlstone Medical and the International Association of Heat and Frost Insulators and Allied Workers Partner to Identify Breath Biomarkers for the Early Detection of Malignant Mesothelioma
Press releases
Owlstone Medical Enters into a Strategic Collaboration with Actelion to Develop a Breath-Based Test to Help Facilitate Early Detection of Pulmonary Hypertension
